Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Difficult to make a case in favor of RXMD when CEO has left shareholders in a vacuum of information. A new CEO should be excited and communicative about his role, not remain silent and keep investors guessing.
I am for, as I own shares, including post split shares. All in good fun.
Are some people for, or against.
I can see why some people are here
That's probably a rough industry these days. People get offended over everything. I second guessed saying "thanks man" to the grocery store cashier this evening because, despite looking male, they had very interesting style, and I didn't feel like getting hassled for using the wrong wordage toward someone. Sad stuff.
At that same grocery store,when I was a little kid, an old man randomly approached me and asked how I got so fat, then told me I needed to get exercise. A lot changed in 25 years.....
Baaaaahahahaha. Dude, you're hysterical. I literally LOL'd on that one. Pre-Shat... priceless! You missed your calling to be a stand up comedian. You could be the next "MACHINE" like Bert Kreisher.
Money is tight. I get my Persian rugs pre shat on. Just place the coffee table over the stain.
Hahahahaha! Like when the dog drops a duce on your newly installed Persian Carpets?
Just use some old news papers.
Start lining up the body bags..... need two for CEO Fernandez and his inflated ego of being a self proclaimed "wizard" of mergers and acquisitions.
RXMD took on worst CEO possible, especially when company was on the cusp of uplisting. All the efforts invested by key personnel of RXMD on the S1 documents along with back and forth with SEC Q&A correspondences all flushed down the drain after keeping investors on the hook for nearly years. They almost had me believing it too.
Shame on your Charles Fernandez.
CEO is the weakest link..... GoodBye!
Painful... Long term debilitation of RXMD
EXACTLY.... they jumping on the AI band wagon. Lost count of how many companies have used the current AI hype on their earnings calls.
Happy Father's Day to all of the dads here who are ensuring their kids grow up rich by owning RXMD.
AI from who? They certainly haven’t created any AI?
I knew it, these Svengalis will say anything to get folks to buy their stock.
I called this exact scenario two weeks and absolutely knew it was just a matter of time before NXPL tossed out the AI buzzword into the zeitgeist and hitched their wagon to the growing trend that is AI.
Refer to Post #169 on NXPL board.
I wouldn't trust AI to write code or even a term paper. Using AI to assess someone's health treatment or dispense medication based on an AI algorithm is just an accident waiting to happen.
Generative & large language model AI are still in its infancy. IMO it will be many years before its incorporated into healthcare.
The system is only as good as it's inputs. And it's programming. An "Expert System" is a long series of questions with answers provided by a human expert. The answer to each question usually leads to another question until one finally gets to some conclusions. In the case of healthcare, which is complex in the extreme, the conclusions will probably lead to more investigation.
$RXMD
The system is only as good as it's inputs. And it's programming. An "Expert System" is a long series of questions with answers provided by a human expert. The answer to each question usually leads to another question until one finally gets to some conclusions. In the case of healthcare, which is complex in the extreme, the conclusions will probably lead to more investigation.
$RXMD
I wouldnt trust anything AI says about my health. Ive heard from lots of people that have gotten wrong answers.
If they can bring in someone who is truly good at creating AI "experts" they could revolutionize healthcare as a whole.
Imagine a General Practitioner logging on and saying "My patient has these symptoms and here are the basic tests I've run, with results. What do you suggest next?". The system then sends the data to an array of "experts" in several medical areas and sends back suggestions on how to narrow the prognosis.
$RXMD
NextPlat will bring AI to Progressive Care, or to a newly combined company as a whole.
As the new Director of Marketing Operations of NextPlat, Progressive Care’s Head of Digital Transformation, Carlos Rangel says: “ We believe in the power of AI to improve preventive healthcare by helping physicians make informed decisions in the Medical Therapy Management process.”
I think you answered the wrong post.
Damn it I forgot we have a family gathering. Can't a guy drink in peace anymore.
Back atcha brother.... and to all the proud Dad's out there Happy Father's Day gentlemen.
Enjoy the weekend with friends and family ;)
July is just around the corner. Hopefully something happens.
Everyone enjoy the weekend.
Nice buy just went thru. 2558 shares @ $4.25
If you're going to throw shade you should get your facts straight. He was asked how he envisioned the company's future. He responded "of course like all other companies, we want to be a billion dollar company." He was just saying that all companies want to be massively successful and that he sees the company's future as successful. The hard monetary value of billions was not the point and is taken out of context. That said, now that they are close with NXPL, who is partnering with Chinese companies, that valuation forecast may not be that far off!
Since they are not merger yet, RXMD should not let those high ranking employees work for another company because they could jeopardize Progressive Care's business secret.
For those investors who still beleive RXMD will achieve the previously mentioned a billion dollar valuation Jay predicted last year, below is some perspective as to why that was the biggest stock farce from the Board of Directors at RXMD. That was the"hook" or "dangling carrot", as some say, to entice investors/buyers before the RS was executed. It was all well orchestrated IMO
Perspective:
Yesterday Cava Group had their IPO on the NYSE. Prior to open trading around noon the Wall Street analysts indicted CAVA had a market cap of $2.58 billion and valued the shares at $22. Currently Cava Group owns and operates 260 Mediterranean casual dining locations across the United States. After yesterday's close, it had a valuation of $4.88B.
So, with that being said......
Anyone on the board care to explain how RXMD, with a fraction of locations, is going to come anywhere close to Jay's absurd prediction of RXMD becoming a billion dollar company in 5 years. Of which, half of one of those years has already passed and still their YoY revenue hovers around $40M over the last 3 years.
Caveat Emptor fellow board members, Chucky Fernandez is truly a Svengali.
How eCommerce Platforms Can Transform Healthcare Provision
June 15, 2023
https://www.biomedwire.com/how-ecommerce-platforms-can-transform-healthcare-provision/
The increased use of internet apps and internet penetration has grown e-commerce globally, with advances being made in various sectors, including the health and wellness market. Estimates from Goldman Sachs predict that the health and wellness business will spend more than $30 billion on e-commerce and associated web service technologies annually.
eCommerce platforms have impacted the healthcare industry in a number of positive ways, starting by making healthcare significantly more accessible online. Below, we look at other impacts e-commerce and telemedicine have had on the healthcare sector.
Improved patient care
Applications such as FirstOpinion and Practo and websites such as YourDoctors. Online and Doctor2U, which offer advice to patients through live chat or text, have eliminated the need for physical doctor visits. It should be noted that in-person tests are sometimes needed by physicians to determine whether further examination in needed.
Changed how people shop online
eCommerce platforms have changed the way clients shop for healthcare products and how these products are delivered to each consumer. Unlike in the past when customers had to visit a physical facility for medicine, you can now make any inquiries via live online chats, purchase healthcare products in the comfort of your home and enjoy fast delivery to your doorstep.
Improved patient experience
The adoption of telemedicine and e-commerce has given rise to a seamless patient experience that allows patients to discuss their symptoms with their doctors, receive a diagnosis and have their prescribed drugs delivered to their homes, all in a matter of hours.
Online sites that allow patients to buy their prescriptions and have them delivered include NowRX and Walgreens.
Streamlined the purchasing process
eCommerce has also afforded physician offices’, hospitals and clinics new ways to speed up their medical supplies and equipment purchases. This comes as more medical device manufacturers move their operations online to enable direct ordering and delivery of equipment. An example of such a company is MedicalExpo, an online exhibition of medical equipment that links suppliers and consumers globally.
What e-commerce trends should we look out for?
The implementation of cutting-edge solutions such as augmented reality (AR) and artificial intelligence (AI) is gaining popularity among startups, a move that may be a game changer for the whole field as its successful adoption will offer additional insights into purchasing behaviors as well as improve customer relationship management.
Additionally, more e-commerce platforms are adopting direct-to-consumer and subscription-based business models, which affords these platforms a greater understanding of consumer preferences and also improves customer retention.
It is likely that as more platforms such as NextPlat Corp. (NASDAQ: NXPL) (NASDAQ: NXPLW) include healthcare products in their offerings, the segment could see new innovations introduced at a faster pace in the way people access healthcare services and products.
NXPL spins off Telesat ---> Acquires RXMD after reaching +50% ownership of Progressive Care ---> A new e-commerce healthcare company built around RXMD with more M/A. Currently NextPlat's CFO, CCO and Director of Marketing are all Progressive Care's active full time employees.
How eCommerce Platforms Can Transform Healthcare Provision
June 15, 2023
https://www.biomedwire.com/how-ecommerce-platforms-can-transform-healthcare-provision/
The increased use of internet apps and internet penetration has grown e-commerce globally, with advances being made in various sectors, including the health and wellness market. Estimates from Goldman Sachs predict that the health and wellness business will spend more than $30 billion on e-commerce and associated web service technologies annually.
eCommerce platforms have impacted the healthcare industry in a number of positive ways, starting by making healthcare significantly more accessible online. Below, we look at other impacts e-commerce and telemedicine have had on the healthcare sector.
Improved patient care
Applications such as FirstOpinion and Practo and websites such as YourDoctors. Online and Doctor2U, which offer advice to patients through live chat or text, have eliminated the need for physical doctor visits. It should be noted that in-person tests are sometimes needed by physicians to determine whether further examination in needed.
Changed how people shop online
eCommerce platforms have changed the way clients shop for healthcare products and how these products are delivered to each consumer. Unlike in the past when customers had to visit a physical facility for medicine, you can now make any inquiries via live online chats, purchase healthcare products in the comfort of your home and enjoy fast delivery to your doorstep.
Improved patient experience
The adoption of telemedicine and e-commerce has given rise to a seamless patient experience that allows patients to discuss their symptoms with their doctors, receive a diagnosis and have their prescribed drugs delivered to their homes, all in a matter of hours.
Online sites that allow patients to buy their prescriptions and have them delivered include NowRX and Walgreens.
Streamlined the purchasing process
eCommerce has also afforded physician offices’, hospitals and clinics new ways to speed up their medical supplies and equipment purchases. This comes as more medical device manufacturers move their operations online to enable direct ordering and delivery of equipment. An example of such a company is MedicalExpo, an online exhibition of medical equipment that links suppliers and consumers globally.
What e-commerce trends should we look out for?
The implementation of cutting-edge solutions such as augmented reality (AR) and artificial intelligence (AI) is gaining popularity among startups, a move that may be a game changer for the whole field as its successful adoption will offer additional insights into purchasing behaviors as well as improve customer relationship management.
Additionally, more e-commerce platforms are adopting direct-to-consumer and subscription-based business models, which affords these platforms a greater understanding of consumer preferences and also improves customer retention.
It is likely that as more platforms such as NextPlat Corp. (NASDAQ: NXPL) (NASDAQ: NXPLW) include healthcare products in their offerings, the segment could see new innovations introduced at a faster pace in the way people access healthcare services and products.
Glad you approve of it. )
Probably the ones who invested in TSLA
LOL...that's pretty funny
Could you be a little more specific
Merger? MERGER???? HAHAHAHAHAHAHAHA
When/if a merger happens, I would Assume the value of the shares we get in the merged company would be based on the value of the shares you own in RXMD at the time… how would you see that working?
Wishful thinking is strong on RXMD, yet no significant milestones accomplished by Fernandez nor PRs to entice potential buyers.
Fernandez is destroying shareholder confidence which Shital Mars worked so hard to build over the years. Anyone else remember when the PPS was in the toilet while CEO Mars was in charge. (naked shorting & note holder exceeding daily conversions allowed by note terms) Under her management she addressed the shareholder concerns on a quarterly conference call? That's what an investment worthy CEO does, Fernandez NOT so much.
While the hopeium runs deep for RXMD,
I placed my bet on Carvana and SOFI, two months into it and over 100% gained.
What? Are you talking about?
Lower the value of our shares at the time of the merger, the less shares we get of nextplat…. That’s what’s happening
I was thinking product agreements are easy, service agreements are alot more complicated. Time will tell.
Well, I've placed my bets on both RXMD and NXPL.
Carlos Rangel, Progressive Care's current Head of Digital Transformation, just started a new position as the Director of Marketing Operations at NextPlat this month. The merger of the two companies is coming sooner than you think.
At one point, my investment in RXMD alone was worth $5M. LMAO. I'm still here posting today. Well, I do think this year will be truly different.
2023 will see a lot of new millionaires
By Q4 RXMD will be in the $20s and hopefully, NXPL will also.
Followers
|
744
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
194975
|
Created
|
01/09/11
|
Type
|
Free
|
Moderators gedi8 Truth022809 stockforce TrackDude MrMike241 |
Progressive Care Gains SEC Reporting Status
See on website
Miami, FL – April 12, 2022 – Globe Newswire via NewMediaWire – Progressive Care, Inc. (OTCQB: RXMD) (the “Company”), a personalized healthcare services and technology provider, today announced that, effective April 11, 2022, its Registration Statement on Form 10 filed with the U.S. Securities and Exchange (the “SEC”) to register its shares of common stock under Section 12(g) of the Securities Exchange Act of 1934 (the “Exchange Act”) became automatically effective.
The effective Form 10 obligates the Company to file Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, in addition to complying with all other obligations under the Exchange Act. In addition, management and certain shareholders are subject to the beneficial ownership reporting requirements of Section 13 and 16 of the Exchange Act.
Alan Jay Weisberg, Chairman and Chief Executive Officer of the Company said, “For me, it was always important to have the Company become fully reporting with the SEC. I know how critical it is for individual and institutional investors to have the Company file its financial reports with the SEC as it provides a higher level of confidence in the information reported by the Company and a superior level of transparency. I believe that the Company’s compliance with the Exchange Act will ultimately help drive shareholder value and enable us to access higher quality institutional capital. We remain committed to strong corporate governance and steadfast in pursuit of our journey to Nasdaq.”
To view the Form 10 filling, please click:
https://www.sec.gov/Archives/edgar/data/0001402945/000149315222009357/form10-12ga.htm
Key Financial Highlights for Year Ended December 31, 2021
• Revenue at $38.9 million
- COVID-19 testing revenue of approximately $4.3 million
- ClearMetrX TPA and pharmacy dispensing revenue related to 340B earned $2.8 million on total billings of $19 million
• Gross margin increased to 26% in 2021, from 23% in 2020
• EBITDA increased to $167,000 in 2021 from $7,000 in 2020
• Cash balance of $1.4 million as of December 31, 2021
Business Highlights for the Year Ended December 31, 2021
• Re-implemented upgraded pharmacy software system
• Expanded COVID-19 business into corporate-focused services and institutional clients
• Strengthened reputation in the 340B sector by adding eight new contracts
• Filed initial S-1 registration statement
• Submitted application for uplisting to Nasdaq
Q4 2021 Reflected a Positive Bounce Back in Business
• Increase of 10% in prescription revenue to $8.9 million in the fourth quarter of 2021, from $8.1 million in the third quarter of 2021
• Increase of 8% in prescriptions filled to 114,000 in the fourth quarter of 2021, from 106,000 in the third quarter of 2021
PRODUCTS AND SERVICES
Advances in HIV/AIDS treatment has greatly increased the ability of those suffering from the disease to manage their symptoms and live longer, healthier lives. Effective management of the disease begins with taking the right medications with the right dose at the right times. For those in the HIV/AIDS community, adhering to the very strict dietary and medicinal requirements can be extremely difficult. Normal activities are often interrupted and sometimes prevented by the struggle to be in compliance.
PharmCo wants to ease this burden on those impacted by this life altering disease. We aim to make compliance with prescription regiments as easy as possible. By understanding the sensitive nature of HIV/AIDS and the needs of those afflicted, PharmCo provides the following services to patients with these special needs:
1. Confidential packaging
2. Packaging tailored to suit a patient's individual life style
3. Free delivery from a variety of sources including PharmCo's proprietary delivery fleet
4. A staff that is well trained in acute illnesses, who understands the patient's needs and
concerns
5. 24 hour emergency support
6. Timely availability of specialty medications due to our extensive inventory
7. Access to newly developed medications
PharmCo is a fully accredited DME supplier. In November 2010, as part of Medicare's competitive bidding, PharmCo was awarded a three year contract to supply hospital beds, oxygen supplies, power wheelchairs, scooters, walkers, and other related equipment and accessories in South Florida. PharmCo carries an extensive inventory of equipment and accessories with most special requests being honored with same day or next day delivery. The company offers both sales and rentals with size, color, style, and brand options available on the majority of products. Most importantly, the staff is knowledgeable, helpful and dedicated to providing superior customer service.
PharmCo offers home service and maintenance, defective product replacements, and free home installation and instruction.
PharmCo's institutional clients have come to depend on the company's proven accuracy, dispensing methods, and immediate response time. With PharmCo compliance and efficiency assistance, long term care institutions are able to provide the highest level of continued care to their patients. PharmCo provides purchasing, repackaging and dispensing of both prescription and non-prescription pharmaceutical products. PharmCo utilizes a unit-of-dose packaging system as opposed to traditional vials used for its retail customers. This method of distribution improves control and patient compliance with recommended drug therapy by increasing the timeliness and accuracy of medication dispensing. PharmCo also provides computerized maintenance of patient prescription histories, third party billing and consultant pharmacist services. Its consulting services consist primarily of evaluation of monthly patient drug therapy and monitoring the institution’s drug distribution system.
Long term care institutions can count on PharmCo for the following services:
1. On time, same day deliveries available twice a day with 24 hour emergency support
2. Language assistance in English, Spanish, French, Creole, Portuguese, Russian, and Hebrew
3. Unit-dose packaging options tailored the facility's needs
4. Prescription data accuracy
5. Extensive medication and DME inventory
6. Access to OTC medications, nutritional products and personal hygiene items
7. Provision and review of medication carts
8. Monthly pharmacy consultations- drug interactions, redundant therapies, side effects, etc.
9. Compliance updates and consultations
10. Staff Training
11. Exceptional customer service.
Toll Free: 888-919-7411 Phone: 305-919-7399 Fax: 305-919-7424
HOURS
Monday- Thursday 8:30 AM - 6:30 PM
Friday 8:30 AM - 6:00 PM
Saturday 11:00 AM - 4:00 PM
PharmCo currently services: Miami-Dade, Broward, Palm Beach, Martin, and St. Lucie Counties.
Progressive Care Reports Full Year 2021 Financial Results Highlighted by $38.9 Million in RevenueGLOBENEWSWIRE – 11:16 AM ET 03/29/2022 |
Progressive Care’s PharmcoRx Gains Status as Approved COVID-19 Test Vendor in the U.S. for Travel to Beijing Winter Olympic Games in ChinaGLOBENEWSWIRE – 7:00 AM ET 02/02/2022
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |